Search results
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
- Pipeline
Biogen. Science & Innovation. Pipeline. Breaking New Ground...
- News Releases
Biogen Receives European Commission Approval for QALSODY®...
- Contact Us
Alzheimer’s Support Alzheimer’s Support Services...
- Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a complex, heterogeneous, chronic...
- Leadership Team
Meet our executive leadership team. Inspired by the science:...
- Investor Relations
Biogen. Corporate Profile. Founded in 1978, Biogen is a...
- Responsibility
For Biogen, that includes bolstering our commitment to...
- Alzheimer's Disease
Biogen has signed agreements with the National Association...
- Pipeline
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Jan 31, 2024 · Biogen will focus on LEQEMBI® (lecanemab-irmb) with Eisai and advancing potential new modalities to address the multiple pathologies of the disease and unmet patient needs. A plan for patients participating in clinical trials or on commercially available treatment is in place.
Biogen is a global biotechnology company that develops innovative medicines for various diseases, including rare and neurological disorders. Follow its LinkedIn page to see its latest news, updates, events, and collaborations in the field of biotechnology research.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
Biogen is a global company that discovers, develops and delivers innovative therapies for neurological and neurodegenerative diseases. Founded in 1978, Biogen has a leading portfolio of medicines for multiple sclerosis, spinal muscular atrophy and other neuroscience fields.